Basics Verve Therapeutics, Inc. IPO Date: July 17, 2021 Sector: Healthcare Industry: Biotech Market Cap: $994.04M Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 3.84% Avg Daily Range (30 D): $0.06 | 0.61% Avg Daily Range (90 D): $0.17 | 3.44% Institutional Daily Volume Avg Daily Volume: 1.13M Avg Daily Volume (30 D): 6.04M Avg Daily Volume (90 D): 4.15M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 241 Avg Trade Size (Sh.) (90 D): 163 Institutional Trades Total Inst.Trades: 1,587 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $2.71M Avg Inst. Trade (90 D): $2.26M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.54M Avg Closing Trade (30 D): $6.46M Avg Closing Trade (90 D): $2.96M Avg Closing Volume: 174.61K     News Jun 20, 2025 @ 2:57 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: N/A Jun 17, 2025 @ 12:07 PM Eli Lilly Expands Into Gene Editing With Verve The... Source: Vandana Singh May 28, 2025 @ 11:00 AM Verve Therapeutics to Participate in Upcoming Inve... Source: N/A May 19, 2025 @ 2:56 PM Bio/Pharmaceutical Outsourcing Report, March 2025 ... Source: Researchandmarkets.Com Apr 18, 2025 @ 10:36 PM Why Verve Therapeutics Zoomed 40% Higher This Week... Source: Eric Volkman Financials   TTM Q1 2025 Q4 2024 Basic EPS $-2.11 $-.35 $-.58 Diluted EPS $-2.11 $-.35 $-.58 Revenue $ 59.61M $ 32.98M $ 13.08M Gross Profit $ $ $ Net Income / Loss $ -181.01M $ -31.03M $ -50.04M Operating Income / Loss $ -208.45M $ -36.64M $ -56.07M Cost of Revenue $ $ $ Net Cash Flow $ -47.65M $ -76.01M $ 13.85M PE Ratio